|
Remuscularization of Injured Ventricle in Large Mammals |
01/10/2025 - 12:00pm to 1:00pm |
|
Assessment of HFpEF Through the Lens of Cardiac Magnetic Resonance |
01/17/2025 - 12:00pm to 1:00pm |
|
Use of dd-cfDNA and GEP: Time for A Change in Paradigm? |
02/07/2025 - 12:00pm to 1:00pm |
|
Lipoprotein(a) in Cardiovascular Disease: Variability, Regulation, and Therapeutic Implications |
02/14/2025 - 12:00pm to 1:00pm |
|
Peripartum Cardiomyopathy: State of the He(art) |
02/21/2025 - 12:00pm to 1:00pm |
|
Cardiomyopathy genetics and gene therapy: are we ready? |
02/28/2025 - 12:00pm to 1:00pm |
|
ATTR Amyloidosis from Diagnosis to Treatment |
03/14/2025 - 12:00pm to 1:00pm |
|
Why Treat CSA in Patients with Cardiac Disease |
03/21/2025 - 12:00pm to 1:00pm |
|
Mechanical Circulatory Support in Infarct Related Cardiogenic Shock |
03/28/2025 - 12:00pm to 1:00pm |
|
The Importance of Signaling Modulations in Obesity, Heart Disease and Fibrosis |
04/11/2025 - 12:00pm to 1:00pm |